Catalyst Biosciences Inc (CBIO.OQ)
CBIO.OQ on NASDAQ Stock Exchange Capital Market
5.24USD
8:27pm IST
5.24USD
8:27pm IST
Change (% chg)
$-0.14 (-2.60%)
$-0.14 (-2.60%)
Prev Close
$5.38
$5.38
Open
$5.46
$5.46
Day's High
$5.46
$5.46
Day's Low
$5.10
$5.10
Volume
35,148
35,148
Avg. Vol
108,068
108,068
52-wk High
$8.90
$8.90
52-wk Low
$3.44
$3.44
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2020 | Jun '20 | 1.66 | -0.964 |
| Mar '20 | 16.37 | -0.278 | |
| FY 2019 | Dec '19 | 0.00 | -1.130 |
| Sep '19 | 0.00 | -1.057 | |
| Jun '19 | 0.00 | -1.149 | |
| Mar '19 | 0.00 | -1.261 | |
| FY 2018 | Dec '18 | 0.00 | -0.907 |
| Sep '18 | 0.00 | -0.644 | |
| Jun '18 | 0.00 | -0.543 | |
| Mar '18 | 0.01 | -0.561 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-20 | 2 | 1.40 | 2.80 | 0.00 | 1.45 |
| Year Ending Dec-20 | 2 | 20.50 | 23.00 | 18.00 | 0.48 |
| Year Ending Dec-21 | 2 | 0.00 | 0.00 | 0.00 | 46.31 |
| Earnings (per share) | |||||
| Quarter Ending Dec-20 | 3 | -0.86 | -0.73 | -0.95 | -1.03 |
| Quarter Ending Mar-21 | 1 | -1.01 | -1.01 | -1.01 | -- |
| Year Ending Dec-20 | 3 | -2.85 | -2.36 | -3.12 | -4.14 |
| Year Ending Dec-21 | 3 | -3.28 | -2.31 | -4.14 | -2.18 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
Dividends
Growth Rates
Financial Strength
Profitability Ratios
Efficiency
Management Effectiveness
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -100.00 | -- | -- |
| EPS (TTM) % | -71.50 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Catalyst Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 21.44 | 16.28 | 87 | -- |
| 13 Week | -7.40 | -12.13 | 44 | -- |
| 26 Week | 8.03 | -11.00 | 46 | -- |
| 52 Week | 0.00 | -12.86 | 41 | -- |
| YTD | -21.00 | -25.52 | 30 | -- |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Catalyst Biosciences Added To Russell 2000 Index
- BRIEF-Catalyst Biosciences Presents Preclinical FIX Gene Therapy Data In Oral Presentation At The World Federation Of Hemophilia Virtual Summit 2020
- BRIEF-Assenagon Asset Management S.A. Reports 6.39% Passive Stake In Catalyst Biosciences Inc
- BRIEF-Catalyst Biosciences Announces Pricing Of Public Offering Of Common Stock
- BRIEF-Catalyst Biosciences Announces Proposed Public Offering Of Common Stock
Institutional Holders
| % Shares Owned: | 63.77% |
| # of Holders: | 108 |
| Total Shares Held: | 14,069,911 |
| 3 Mo. Net Change: | -154,435 |
| # New Positions: | 3 |
| # Closed Positions: | 4 |
| # Increased Positions: | 6 |
| # Reduced Positions: | 5 |
| # Net Buyers: | 1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.